Hi Doc, the actual Human Trial stated the dose was good, results were brilliant against the actual cancer , the Human trial was halted to reformulate for palatability in 2016.. this was also a Phase i for safety that was passed..
Regulatory permission was given in 2016 for a Phase IIb Human Cancer Trial...https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=366350
so with a Human Trial having been completed and a lengthy safety record supplied with MPL , why hasn't PAA applied for Fast Track approval? or under emergency measures? for Covid Treatment ,,,
Another company a few of us are invested in have just had medication crushed and added to liquid to pour down Cov19 patients throats to deliver the treatment in India... as the regs there have been kicked into touch,,,, that's because 270,000 Indians contracted Covid Yesterday..
Maybe PAA are to focused seeking the goldilocks formula? lets get MPL into a Human "again".... and you don't need 10kgs for a phase I,, most Phase I are on an R and D batch of pills,,, then they move to GMP for phase II and III..
Cant but help think PAA were way ahead of the Covid pack in April last year.... Now?
- Forums
- ASX - By Stock
- Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity
Hi Doc, the actual Human Trial stated the dose was good, results...
Featured News
Add NUZ (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.0¢ |
Change
0.015(8.11%) |
Mkt cap ! $98.34M |
Open | High | Low | Value | Volume |
19.0¢ | 20.0¢ | 19.0¢ | $66.44K | 346.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 86359 | 19.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.0¢ | 107894 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 86359 | 0.190 |
14 | 839962 | 0.185 |
8 | 336753 | 0.180 |
4 | 120797 | 0.175 |
5 | 159661 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.200 | 107894 | 5 |
0.205 | 109808 | 2 |
0.210 | 107676 | 2 |
0.215 | 154400 | 2 |
0.220 | 174409 | 3 |
Last trade - 15.42pm 13/11/2024 (20 minute delay) ? |
Featured News
NUZ (ASX) Chart |